Close Alert

Return to Campus Update

Coronavirus (COVID-19): The latest updates about USciences return to campus: The full plan for a phased return of employees and students:

USciences Joins Philadelphia Research Consortium

Research ConsortiumUniversity of the Sciences has joined the The Wistar Institute, and many regional academic institutions who are driving life sciences discoveries, to launch the Philadelphia Research Consortium – a preclinical research network for facilitating easy access to our region’s robust research enterprise.

“This is a crucial partnership for USciences that will lead to fruitful collaborations with the Philadelphia academic research community and corporate partners,” said Jean-Francois Jasmin, PhD, Associate Provost for Research and Graduate Education.

Spearheading the Consortium’s launch is Heather A. Steinman, PhD, MBA, Wistar’s vice president for business development and executive director of technology transfer, whose shared vision for the alliance is two-fold: enable transformative, potentially lifesaving scientific progress, and catalyze productive, long-term collaborations between the Philadelphia academic research community and for-profit research and development partners, specifically targeting life sciences start-ups.

As of now, representatives from technology commercialization offices at the following organizations have joined the Consortium: Baruch S. Blumberg Institute, Children’s Hospital of Philadelphia, Children’s National Health System, Drexel University, Lankenau Institute for Medical Research (part of Main Line Health), Lehigh University, Monell Chemical Senses Center, Penn State, Penn State College of Medicine, Temple University, The Wistar Institute, Thomas Jefferson University, and University of the Sciences.

“The end goal is to facilitate preclinical collaboration between start-ups and our research labs,” said Dr. Steinman. “Instead of using resources to support infrastructure, our partners can utilize their capital to support preclinical research across the region while advancing and de-risking their own programs. We have all the talent, research and resources in Philadelphia—all working together to create a vibrant life sciences ecosystem.”

The Consortium allows for local, national and international startup and biotech partners to leverage the collective research strengths of Philadelphia’s vibrant life sciences community. Partners can focus on the key experiments required to advance therapeutic programs through to proof-of-concept without negotiating multiple, often cumbersome, contracts. Such relationships between research institutions and biotech partners could increase the likelihood of innovative early stage discoveries successfully moving from the laboratory to the marketplace.

To this end, members of the Philadelphia Research Consortium have made a pledge to the startup and biotech community to use a universal, sponsored research agreement with all potential partners interested in exploring preclinical discovery research with participating institutions where applicable. Steinman sees the user-friendly tool as an invitation for startups to unite with partners across the area’s biomedical research community.

For more information about the Philadelphia Research Consortium, visit

Categories: Announcement, News, Research, USciences, Misher College, Philadelphia College of Pharmacy